Physician profile
Donald E Harrison
NPI 1134376247
$112,362.35
in general payments reported to CMS, 2019-2025
15 companies · $61.47 in 2025
The $61.47 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $906 · 2020: $1,633 · 2022: $2,887 · 2023: $202 · 2024: $107K · 2025: $61.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $106K · Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $106,400.00 |
| Food and Beverage | $536.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $106,400.00 | 2024 | |
| Supreme Orthopedic Systems, LLC | $3,056.58 | 2019-2022 | |
| Triad Life Sciences INC. | $1,617.32 | 2022 | |
| Organogenesis INC. | $363.05 | 2019-2023 | Puraply |
| Arthrex, INC. | $278.08 | 2022 | |
| Treace Medical Concepts, INC. | $274.67 | 2024-2025 | |
| Smith+Nephew, INC. | $151.79 | 2019-2020 | |
| Alafair Biosciences, INC. | $73.50 | 2022 | |
| Bioventus LLC | $37.11 | 2024 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $25.91 | 2023 | Entre Plus, Flexitouch Plus |
| Kci USA, INC. | $25.42 | 2019 | |
| Averitas Pharma INC. | $21.90 | 2025 | Qutenza |
| Synergy Orthopedics, LLC | $13.25 | 2022 | |
| Horizon Therapeutics Plc | $11.91 | 2019 | |
| Misonix INC | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.